SNOA Sonoma Pharmaceuticals
- 0.1580
- +0.0031+2.00%
Sonoma Pharmaceuticals News
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
BOULDER, CO / ACCESSWIRE / May 9, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid
Sonoma Pharmaceuticals Presents Business and Financial Update
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid
Express News | Sonoma Reports Recent Publication From Australia Highlighting Potential For Microdox In Managing Urinary Tract Infections
Express News | Sonoma Pharmaceuticals Reported A Recent Publication In The Journal Neurourology And Urodynamics Highlighting The Potential For Microdox In The Management Of Urinary Tract Infections In Children With Neurogenic Or Non‐Neurogenic Bladder Dysfunction
Sonoma Pharmaceuticals Reports Recent Publication From Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous ac
Sonoma Pharmaceuticals Outlines Growth and Challenges
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) shares rose 328.2% to $20.34 during Thursday's pre-market session. The company's market cap stands at $16.3 million. Xilio Therapeutics (NASDAQ:XLO) stock moved
Sonoma Pharmaceuticals Highlights Safety Advantages of Its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
BOULDER, CO / ACCESSWIRE / March 27, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous a
Express News | Sonoma Pharmaceuticals Q3 EPS $(0.08) Up From $(0.62) YoY, Sales $3.14M Up From $2.94M YoY
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
Revenues increased 7% compared to quarter from prior year and 15% from prior quarterImprovement in gross margin for quarter of 19% compared to prior yearImprovement in net loss for quarter of $1.0 mil
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersKura Oncology (NASDAQ:KURA) stock rose 39.6% to $18.73 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.3 billion. Redhill Biopharma (NASDAQ:RDHL) st
Express News | Sonoma Pharmaceuticals Announced The Launch Of Lumacyn Clarifying Mist Direct To Consumers For Over-the-counter Use In The United States
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
BOULDER, CO / ACCESSWIRE / January 23, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid
12 Health Care Stocks Moving In Monday's Intraday Session
GainersAtreca (NASDAQ:BCEL) stock rose 52.7% to $0.36 during Monday's regular session. The market value of their outstanding shares is at $14.1 million. Cyclo Therapeutics (NASDAQ:CYTH) shares rose 29
NovaBay Pharmaceuticals And Sonoma Pharmaceuticals Agree To Market Avenova-Branded Products In European Union; Sonoma Will Manufacture Ocudox And Pay NovaBay Royalty Fee Based On Net Product Sales
The new products will combine Sonoma's existing eye product Ocudox, which has already received a Class IIB CE mark for sale in the European Union, with Avenova branding, and are expected to be markete
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAllarity Therapeutics (NASDAQ:ALLR) shares rose 44.0% to $0.86 during Tuesday's pre-market session. The company's market cap stands at $3.9 million. Sonoma Pharmaceuticals (NASDAQ:SNOA) stock r
Sonoma Pharmaceuticals GAAP EPS of -$0.29 Misses by $0.05, Revenue of $2.73M Misses by $0.75M
Sonoma Pharmaceuticals Q2 EPS $(0.29) Misses $(0.24) Estimate, Sales $2.73M Miss $3.48M Estimate
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 12.12 percent increase over losse
Analysis
Price Target
No Data
